Hepatocyte growth factor and vitamin D cooperatively inhibit androgen-unresponsive prostate cancer cell lines

Endocrinology

Volumn 141, Issue 7, 2000, Pages 2567-2573

  Qadan, Laila R ^a,b,c   Perez Stable, Carlos M ^a,b,c   Schwall, Ralph H ^d   Burnstein, Kerry L ^a,b,c   Ostenson, Richard C ^e   Howard, Guy A ^a,b,c   Roos, Bernard A ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI   (United States)

^d GENENTECH INC   (United States)

^e Good Samaritan Cancercare and Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; VITAMIN D;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION;

EID: 0034457891     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.7.7546     Document Type: Article

References (50)

1. 3 receptors and actions in human prostate cancer cell lines
2. 3 on primary culture of human prostatic cells
3. The role of vitamin D in normal prostate growth and differentiation
4. 3 in seven human prostatic carcinoma cell lines
5. Human prostate cancer cells: Inhibition of proliferation by vitamin D analogs
6. 3 and prostate cancer cell proliferation in vivo
7. Vitamin D receptor content and transcriptional activity do not fully predict antiproliferative effects of vitamin D in human prostate cancer cell lines
8. Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells
9. Scatter factor
10. Identification of the hepatocyte growth factor receptor as the c-met protooncogene product
11. Hepatocyte growth factor has potent antiproliferative activity in various tumor cells lines
12. Inhibitory effect of hepatocyte growth factor on metastasis of hepatocellular carcinoma in transgenic mice
13. Met-HGF/SF mediates growth arrest and differentiation in T47D breast cancer cells
14. Hepatocyte growth factor is a paracrine regulator of rat prostate epithelial growth
15. c-met proto-oncogene expression in benign and malignant human prostate tissues
16. The developmental pattern of androgen receptor expression in rat prostate lobes is altered after neonatal exposure to estrogen
17. Gene activity during the early phase of androgen-stimulated rat prostate regrowth
18. Regulation of prostate growth
19. Changes in gene expression of growth factors and their receptors during castration-induced involution and androgen-induced regrowth of rat prostates
20. Biomarkers associated with prostate cancer progression
21. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice
22. Hepatocyte growth factor and its actions in growth plate chondrocytes
23. Sulfated oligosaccharides promote hepatocyte growth factor association and govern its mitogenic activity
24. Isolation of a human prostate carcinoma cell line (DU 145)
25. LNCaP model of human prostatic carcinoma
26. Establishment and characterization of a human prostatic carcinoma cell line (PC-3)
27. Human primary prostate tumor cell line, ALVA-31: A new model for studying the hormonal regulation of prostate tumor cell growth
28. Absence of androgen-mediated transcriptional effects in osteoblastic cells despite presence of androgen receptors
29. Purification of mouse immunoglobulin heavy chain messenger RNAs from total myeloma tumor DNA
30. Modulation of motility and proliferation of glioma cells by hepatocyte growth factor
31. Prostate cancer progression, metastasis, and gene expression in transgenic mice
32. Hepatocyte growth factor and hepatocyte growth factor receptor in the lacrimal gland, tears, and cornea
33. Use of flow cytometry for DNA analysis
34. Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma
35. Hepatocyte growth factor inhibits cell proliferation in vivo of rat hepatocellular carcinomas induced by diethylnitrosamine
36. A fibroblast-derived tumor cytotoxic factor/F-TCF (hepatocyte growth factor/HGF) has multiple functions in vitro
37. Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model
38. Regulation of invasive potential of human prostate cancer cell lines by hepatocyte growth factor
39. 3 in the human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation
40. 3 and the regulation of human cancer cell replication
41. 1
42. 3 actions in LNCaP human prostate cancer cells are androgen-dependent
43. Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma
44. CDKN4) in human prostate cancers
45. Cell cycle checkpoints: Preventing an identity crisis
46. Cancer cell cycle
47. The retinoblastoma protein and cell cycle control
48. Expression of cell cycle-regulated proteins in prostate cancer
49. Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor
50. Induction of liver growth in normal mice by infusion of hepatocyte growth/scatter factor